Sign in
4/A

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-20-000638

FORMER CHIEF BUSINESS OFFICER gave up 2,045 shares (to pay taxes)

  • FORMER CHIEF BUSINESS OFFICER acquired 6,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Snow David P. · FORMER CHIEF BUSINESS OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-01-30 Exercise or conversion : show line 1 in the form +6,250 6,250 D
2020-01-30 Shares withheld for taxes : show line 2 in the form −2,045 $3.91 $7,996 4,205 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-01-30 Exercise or conversion : show line 3 in the form Restricted Stock Units −6,250 18,750 D
Loading xslF345X03/form4a-03042020_020311.xml…